Celldex Therapeutics Stock Math Transform Price Ceiling Movement
| CLDX Stock | USD 30.84 1.41 4.79% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Celldex Therapeutics Price Ceiling Movement function is a real number to the largest previous price integer.
Celldex Therapeutics Technical Analysis Modules
Most technical analysis of Celldex Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Celldex from various momentum indicators to cycle indicators. When you analyze Celldex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
How Much Is Celldex Therapeutics Worth?
Celldex Therapeutics is a mid-cap equity in Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care categories. Peer comparison highlights relative pricing efficiency. We evaluate Celldex Therapeutics through the lens of long-term portfolio construction and diversification efficiency.
Methodology
Unless otherwise specified, financial data for Celldex Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Celldex (USA Stocks:CLDX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
The dataset for Celldex Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Celldex Therapeutics is covered by 16 analysts. 8 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Stifel, Barclays, Morgan Stanley, Wells Fargo Securities, Evercore ISI, BMO Capital Markets, HSBC Global Research, Jefferies, J.P. Morgan, Bernstein Research, among others. Updates may occur throughout the day.
Align your values with your investing style
Using Celldex Therapeutics inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Hedge Favorites Invested over 20 shares | |
 | Synthetics Invested over 60 shares | |
 | Momentum Invested over 200 shares | |
 | Macroaxis Index Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Macroaxis Picks Invested few shares | |
 | Investor Favorites Invested over 60 shares | |
 | Baby Boomer Prospects Invested over 20 shares | |
 | Driverless Cars Invested over 200 shares | |
 | FinTech Invested over 20 shares | |
 | Blockchain Invested few shares |
More Resources for Celldex Stock Analysis
A structured review of Celldex Therapeutics often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Celldex Therapeutics Stock in context:Use Trending Equities to better understand diversified portfolio construction. Additional portfolio transparency improves capital positioning. This includes a position in Celldex Therapeutics across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. For more information on how to buy Celldex Stock please use our How to Buy Celldex Stock guide.Analysis related to Celldex Therapeutics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Earnings Share -3.90 | Revenue Per Share | Quarterly Revenue Growth -0.90 | Return On Assets | Return On Equity |
The market value of Celldex Therapeutics is measured differently than book value, which reflects Celldex accounting equity. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Market price responds to sentiment, liquidity, and macro shifts, so gaps can appear. Valuation work aligns these measures into a single context.
Note that Celldex Therapeutics' intrinsic value and market price are different measures derived from different inputs. Context can include financial performance, operating efficiency, market trends, and peer comparisons. Trading price represents the transaction level agreed by market participants.